CODX Live signaler | Maksimer profitt med Getagraph.com

Live Chart Being Loaded With Signals

Commentary (2 mai 2024 @ 22:00):

Stats
Dagens volum	32 820.00
Gjennomsnittsvolum	57 568.00
Markedsverdi	37.51M
EPS	$0 ( 2024-03-14 )
Neste inntjeningsdato	( $-0.210 ) 2024-05-09
Last Dividend	$0 ( N/A )
Next Dividend	$0 ( N/A )
P/E	-1.000
ATR14	$0.00800 (0.67%)

Insider Trading

Date	Person	Action	Amount	type
2024-04-26	Abbott Richard David	Buy	120 000	Restricted Stock Units
2024-04-26	Brown Brian Lee	Buy	225 000	Restricted Stock Units
2024-04-26	Egan Dwight H	Buy	275 000	Restricted Stock Units
2024-04-26	Durenard Eugene	Buy	110 000	Restricted Stock Units
2024-04-26	Serbin Richard S	Buy	110 000	Restricted Stock Units

INSIDER POWER
53.26
Last 97 transactions
Buy: 4 111 333 \| Sell: 1 326 351

Co-Diagnostics Inc Korrelasjon

10 Mest positive korrelasjoner
FLNT	0.981
FFWM	0.976
TOI	0.972
FSEA	0.969
MRBK	0.969
ESPR	0.963
CASA	0.963
PFSW	0.963
PTVE	0.963
PACW	0.962

10 Mest negative korrelasjoner
SUMO	-0.974
DSPG	-0.96
DRNA	-0.952
STAY	-0.949
PPD	-0.94
MMAC	-0.938
SMED	-0.935
NVCN	-0.935
AMRB	-0.934
FTIV	-0.933

Visste du det?

Korrelasjon er en statistisk måling som beskriver forholdet mellom to variabler. Den varierer fra -1 til 1, hvor -1 indikerer en perfekt negativ korrelasjon (hvor en variabel øker, går den andre ned), 1 indikerer en perfekt positiv korrelasjon (hvor en variabel øker, går den andre også opp), og 0 indikerer ingen korrelasjon (det er ingen forhold mellom variablene).

Korrelasjon kan brukes til å analysere forholdet mellom to variabler, ikke bare aksjer. Det er vanligvis brukt innen områder som finans, økonomi, psykologi, og mer.

Co-Diagnostics Inc Økonomi

Annual	2023
Omsetning:	$991 473
Bruttogevinst:	$-4.42M (-446.20 %)
EPS:	$-1.200

FY	2023
Omsetning:	$991 473
Bruttogevinst:	$-4.42M (-446.20 %)
EPS:	$-1.200

FY	2022
Omsetning:	$34.22M
Bruttogevinst:	$28.74M (83.98 %)
EPS:	$-0.450

FY	2021
Omsetning:	$97.89M
Bruttogevinst:	$86.31M (88.18 %)
EPS:	$1.270

Financial Reports:

No articles found.

Co-Diagnostics Inc

Co-Diagnostics, Inc., a molecular diagnostics company, develops, manufactures, and sells reagents used for diagnostic tests that function through the detection and/or analysis of nucleic acid molecules in the United States and internationally. It offers polymerase chain reaction (PCR) diagnostic tests for COVID-19, tuberculosis, hepatitis B and C, human papilloma virus, malaria, chikungunya, dengue, and the zika virus; three multiplexed tests to test mosquitos for the identification of diseases carried by the mosquitos; and molecular tools for detection of infectious diseases, liquid biopsy for cancer screening, and agricultural applications. The company also provides tests that identify genetic traits in plant and animal genomes; and portable PCR device designed to bring PCR to patients in point-of-care and at-home settings. In addition, it intends to sell diagnostic equipment from other manufacturers as self-contained lab systems. The company was incorporated in 2013 and is headquartered in Salt Lake City, Utah.